Who owns GAIN THERAPEUTICS INC?
- Ticker: GANX
- CUSIP Number: 36269b105
Tip: Access positions for across all investors
Analyze quarterly positions in Gain Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Gain Therapeutics stock
Who bought or sold GAIN THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Marshall Wace | 1.7M | $5.4M | 849% | Dec 2025 |
|
| Potomac Capital Management | 1.0M | $3.3M | 100% | Dec 2025 |
|
| Susquehanna International | 729k | $2.3M | 806% | Dec 2025 |
|
| Jones Financial Companies, L.L | 702k | $2.3M | 4% | Dec 2025 |
|
| Vanguard Group | 570k | $1.8M | 7% | Dec 2025 |
|
| Cambridge Investment Research Advisors | 569k | $1.8M | 78% | Dec 2025 |
|
| DME Capital Management | 566k | $1.8M | 0% | Dec 2025 |
|
| Geode Capital Management | 398k | $1.3M | 16% | Dec 2025 |
|
| Jane Street | 242k | $780k | 234% | Dec 2025 |
|
| BlackRock | 210k | $675k | 80% | Dec 2025 |
|
| Cresset Asset Management | 160k | $515k | 100% | Dec 2025 |
|
| State Street Corporation | 158k | $507k | 73% | Dec 2025 |
|
| LPL Financial | 107k | $343k | 100% | Dec 2025 |
|
| Northern Trust | 102k | $328k | 15% | Dec 2025 |
|
| UBS Group | 81k | $261k | -42% | Dec 2025 |
|
| Colony | 78k | $251k | 100% | Dec 2025 |
|
| Citadel Advisors | 78k | $250k | -80% | Dec 2025 |
|
| Hrt Financial | 56k | $179k | 182% | Dec 2025 |
|
| Group One Trading | 54k | $174k | 223% | Dec 2025 |
|
| Simplex Trading | 48k | $154k | 100% | Dec 2025 |
|
| OMERS Administration Corporation | 37k | $120k | 100% | Dec 2025 |
|
| Springbok Capital Management | 36k | $115k | 0% | Dec 2025 |
|
| Goldman Sachs Group | 33k | $105k | 100% | Dec 2025 |
|
| Point72 Asset Management | 33k | $105k | 100% | Dec 2025 |
|
| Bridgeway Capital Management | 30k | $97k | 0% | Dec 2025 |
|
| Apollon Wealth Management | 27k | $51k | 34% | Mar 2026 |
|
| Lighthouse Investment Partners | 23k | $74k | 100% | Dec 2025 |
|
| GSA Capital Partners | 21k | $66k | 100% | Dec 2025 |
|
| Oliver Luxxe Assets | 20k | $39k | 0% | Mar 2026 |
|
| Renaissance Technologies | 17k | $56k | -86% | Dec 2025 |
|
| Sontag Advisory | 17k | $54k | 100% | Dec 2025 |
|
| Benedict Financial Advisors | 16k | $30k | -59% | Mar 2026 |
|
| Sandhill Capital Partners | 15k | $50k | 0% | Dec 2025 |
|
| Engineers Gate Manager | 15k | $47k | 100% | Dec 2025 |
|
| Millennium Management | 14k | $45k | 100% | Dec 2025 |
|
| Commonwealth Equity Services | 13k | $41k | 100% | Dec 2025 |
|
| Kestra Advisory Services | 12k | $39k | 0% | Dec 2025 |
|
| Sprott | 12k | $39k | 100% | Dec 2025 |
|
| Goss Wealth Management | 11k | $34k | 0% | Dec 2025 |
|
| Tower Research Capital | 6.9k | $22k | 232% | Dec 2025 |
|
| MAI Wealth Advisors | 4.4k | $14k | 0% | Dec 2025 |
|
| Wells Fargo & Company | 2.7k | $8.5k | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 2.4k | $7.7k | 100% | Dec 2025 |
|
| State of Wyoming | 1.4k | $4.6k | 100% | Dec 2025 |
|
| Larson Financial Group | 10.00 | $32.000000 | 100% | Dec 2025 |
|
Who sold out of Gain Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| XTX Topco | Sep 2025 | 54k | $96k |
| Virtu Financial | Sep 2025 | 54k | $96k |
| Kovitz Investment Group Partners | Sep 2025 | 48k | $84k |
| Squarepoint Ops | Sep 2025 | 39k | $68k |
| Two Sigma Securities | Sep 2025 | 27k | $48k |
| Wealth Enhancement Advisory Services | Dec 2025 | 16k | $40k |
| HighTower Advisors | Sep 2025 | 12k | $21k |
| Armis Advisers | Sep 2025 | 11k | $20k |
| SRS Capital Advisors | Sep 2025 | 3.3k | $5.8k |
| FNY Investment Advisers | Dec 2025 | 2.0k | $6.0k |